All In MedTech

FDA Clearance Tracker · P150030-S045

R3 Delta Ceramic Hip System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 28, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P150030-S045
Device name
R3 Delta Ceramic Hip System
Applicant location
Memphis, TN
Received
Sep 3, 2024
Decided
Feb 28, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P150030

Device type

Device class
Class III

Every decision under product code MRA

FDA's approval statement

As written in FDA's record.

Approval for revisions to device labeling that was updated to include information on the Post-Approval Study (PAS), Short to Mid-term f/u of New US patients PAS, for the R3 Delta Ceramic Hip System.

Source documents

Other decisions for Smith & Nephew, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.